Peripartum cardiomyopathy: Moving towards a more central role of genetics

Current Cardiology Reviews

Volumn 9, Issue 3, 2013, Pages 179-184

  Cemin, Roberto ^a   Janardhanan, Rajesh ^c   Donazzan, Luca ^a   Daves, Massimo ^b  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

^b San Maurizio Regional Hospital   (Italy)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Echocardiogaraphy; Heart failure; Peripartum cardiomyopathy

Indexed keywords

BROMOCRIPTINE; DOBUTAMINE; PROLACTIN;

ANTICOAGULANT THERAPY; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CARDIOGENIC SHOCK; CONVALESCENCE; EARLY DIAGNOSIS; EXTRACORPOREAL OXYGENATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEMODYNAMIC STRESS; HEREDITY; HORMONE SYNTHESIS; HUMAN; HYPOXEMIA; INFLAMMATION; MATERNAL HYPERTENSION; MILK PRODUCTION; MORTALITY; MULTIPARA; MYOCARDITIS; PATHOGENESIS; PERINATAL PERIOD; PERIPARTUM CARDIOMYOPATHY; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; RELAPSE; SIDE EFFECT;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BROMOCRIPTINE; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART FAILURE; HUMANS; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY, TWIN; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84882736599     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/1573403X113099990029     Document Type: Article

References (53)

1. Cemin R, Janardhanan R, Daves M. Peripartum cardiomyopathy: an intiguing challenge. Case report with literature review. Curr Cardiol Rev 2009; 5: 268-72.
2. Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation 1971; 44: 964-8.
3. Ansari AA, Fett JD, Carraway RE, Maayne AE, Ollamoon M, Sundstrom JB. Autoimmune mechanism as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 2002; 23: 301-24.
4. Fett JD, Sundstrom JB, Ansari AA, Combs GF. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol 2002; 86: 311-5.
5. Kothari SS. Aetiopathogenesis of peripartum cardiomyopathy: prolactin-selenium interaction. Int J Cardiol 1997; 60: 111-4.
6. Kuhl U, Pauschinger M, Seeberg B et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005; 112: 1965-70.
7. Anderson JL, Horne BD. Birthing the genetics of peripartum cardiomyopathy. Circulation 2010; 121: 2157-9.
8. Horne BD, Rasmusson KD, Alharethi R, et al. Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy. Circ Cardiovasc Genet 2011; 4(4): 359-66.
9. Pearson GD, Veille JC, Rahimtoola S, et al. National Heart, Lung and Blood Institute and Office of Rare Diseases Workshop recommendations and reviews. JAMA 2000; 283: 1183-8.
10. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010; 12: 767-8.
11. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomiopathy at a single insitution. Mayo Proceed 2005; 80:1602-6.
12. Brar SS, Khan SS, Sandhu KG, et al. Incidence, mortality and racial differences in peripartum cardiomiopathy. Am J Cardiol 2007; 100:302-4.
13. Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardyiomiopathy. Clinical Characteristics and a comparison between early and late presentation. Circulation 2005; 111: 2050-5.
14. Hibbard JU, Lindenheimer Ml Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Ostet Gynecol 1999; 94: 311-6.
15. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006; 368: 687-93.
16. Fett JD, Carraway RD, Dowell DL, King ME, Pierre R. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gnecol 2002; 186: 1005-10.
17. Sliwa K, Forster O, Libhaber E, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006; 27: 441-6.
18. Ray P, Murphy G, Shutt L. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth 2004; 93: 428-39.
19. Melvin KR, Richardson PJ, Olsen EG, et al. Peripartum cardiomyopathy due to myocarditis. N Engl J Med 1982; 307: 731-4.
20. Sanderson JE, Olsen EG, Gatei D. Peripartum heart disease: an endomyocardial biopsy study. Br Heart J 1986; 56: 285-91.
21. O'Connell JB, Costanzo-Nordin MR, Subramanian R, et al. Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol 1986; 8: 52-6.
22. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-84.
23. Rizeq MN, Rickenbacher PR, Fowler MB, et al. Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 1994; 74: 474-7.
24. Bianchi DW. Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet 2000; 91(1): 22-8
25. Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypotesis. Lancet 2000; 346(9233): 930-3.
26. Warraich RS, Fett JD, Damasceno A, et al. Impact of Pregnancy related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulinss in peripartum Cardiomyopathy. Am Heart J 2005; 150: 263-9.
27. Blauwet LA, Cooper LT. Diagnosis and management of peripartum cardiomyopathy. Heart 2011; 97: 1970-81.
28. Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypotesis. Lancet 2000; 346(9233): 930-3.
29. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin Dcleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007; 128: 589e600.
30. Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed JL. African-American women have a higher risk for developing peripartum cardiomiopathy. J Am Coll Cardiolm 2010; 55: 654-9.
31. Pierce JA, Price BO, Joyce JW. Familial occurrence of postpartal heart failure. Arch Intern Med 1963; 111: 651-5.
32. Meyer GP, Labidi S, Podewski E, et al. Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports. J Med Case Reports 2010; 4: 80.
33. Fett JD. Peripartum cardiomyopathy in both surrogate and biological mother. Hum Reprod 2005; 20(9): 2666-8.
34. Morales A, Painter T, Li R, et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010; 121: 2176-82.
35. van Spaendonck-Zwarts K, van Tintelen J, van Veldhuisen DJ, et al. Peripartum cardiomyopathy as part of familial dilated cardiomyopathy. Circulation 2010; 121: 2169-75.
36. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000; 35(3): 701-5.
37. Dorbala S, Brozena S, Zeb S, et al. Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiogr 2005; 18(1): 45-8.
38. Kaaja R. Peripartum cardiomiopathy. Minerva Cardioangiol 2006; 54(3): 331-6.
39. Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomiopathy. Obstet Gynecol 2005; 105(6): 1303-8.
40. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 2006; 152(3): 509-13.
41. Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol 2007; 118(3): 295-303.
42. Benlolo S, Lefoll C, Katchatouryan V, Payen D, Mebazaa A. Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg 2004; 98(3): 822-4.
43. Yang HS, Hong YS, Rim SJ, Yu SH. Extracorporeal membrane oxigenation in a patient with peripartum cardiomyopathy. Ann Thorac Surg 2007; 84(1): 262-4.
44. Ardehali H, Kasper EK, Baughman KL. Peripartum cardiomyopathy. Minerva Cardioangiol 2003; 51(1): 41-8.
45. Sliwa K, Blauwert L, Tibizarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof of concept pilot study. Circulation 2010; 121:1465-73.
46. Hilfiker-Kleiner D, Meyer GP, Schieffer E, Goldmann B, Podewski E, Struman I, Fischer P, Drexler H. Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol 2007; 50: 2354-5.
47. Habedank D, Kuhnle Y, Elgeti T, Dudenhausen JW, Haverkamp W, Dietz R. Recovery from peripartum cardiomyopathy after treatment with bromocriptine. Eur J Heart Fail 2008; 10: 1149-51.
48. Jahns BG, Stein W, Hilfiker-Kleiner D, Pieske B, Emons G. Peripartum cardiomyopathy-a new treatment option by inhibition of prolactin secretion. Am J Obstet Gynecol 2008; 199: e5-e6.
49. Fett JD. Caution in the use of bromocriptine in peripartum cardiomyopathy. J Am Coll Cardiol 2008; 51: 2083.
50. Mishra TK, Swain S, Routray SN. Peripartum cardiomyopathy. Int J Gynaecol Obstet 2006; 95(2): 104-9.
51. Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001; 344(21): 1567-71.
52. Hershberger RE. Cardiovascular genetic medicine: evolving concepts, rationale and implementation. J Cardiovasc Trans Res. 2008; 1: 137-43.
53. Robin NH, Tabereaux PB, Benza R, Korf BR. Genetic testing in cardiovascular disease. J Am Coll Cardiol 2007; 50: 727-37.